Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Published 13/02/2023, 19:12
© Reuters.  Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga - Gainers

  • Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
  • Top Ships Inc. (NASDAQ: TOPS) gained 37.2% to $1.7985 after the company entered into a time charter employment contract.
  • COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 34.7% to $5.86 after the company announced an 80% year-over-year reduction of outstanding secured debt.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) shares gained 33.6% to $5.17 after the company announced interim 10-month data from an ongoing U.S. Phase 1 clinical trial evaluating OTX-TKI for the treatment of wet AMD.
  • MMTec, Inc. (NASDAQ: MTC) surged 28% to $0.9119.
  • Fastly, Inc. (NYSE: FSLY) climbed 25.8% to $12.44 after B of A Securities upgraded the stock from Underperform to Buy and raised its price target from $10.50 to $16.
  • Pagaya Technologies Ltd. (NASDAQ: PGY) gained 21% to $1.49.
  • China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) surged 21% to $5.99 after the company announced a $2.625 million registered direct offering.
  • Venus Concept Inc. (NASDAQ: VERO) gained 19.4% to $0.2921. Venus Concept recently announced a restructuring plan, workforce reduction, management transition, and preliminary unaudited revenue results.
  • Expion360 Inc. (NASDAQ: XPON) shares climbed 18.5% to $3.62. Expion360 shares jumped over 55% on Friday after the company announced it has been selected by Cube Series as the exclusive supplier of lithium-ion batteries for a ultra-lightweight foldable campler.
  • Clene Inc. (NASDAQ: CLNN) gained 17.8% to $1.59 after the company reported new data from the VISIONARY-MS Phase 2 study in multiple sclerosis demonstrating CNM-Au8 treatment improved brain neuronal structural integrity.
  • VistaGen Therapeutics, Inc. (NASDAQ: VTGN) jumped 17.2% to $0.2110.
  • LuxUrban Hotels Inc. (NASDAQ: LUXH) surged 16.5% to $2.1550.
  • Asset Entities Inc. (NASDAQ: ASST) jumped 16.1% to $2.02.
  • monday.com Ltd. (NASDAQ: MNDY) surged 15.2% to $151.17 after the company reported better-than-expected Q4 adjusted EPS and sales results and issued Q1 and FY23 guidance.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) gained 14.8% to $1.8250. Hillstream BioPharma inked HER2 and HER3 license deal with Applied Biomedical Science Institute for potential treatments against drug resistant cancers.
  • Diebold Nixdorf, Incorporated (NYSE: DBD) surged 13.2% to $2.3550. Diebold Nixdorf recently reported worse-than-expected Q4 sales results.
  • Teradata Corporation (NYSE: TDC) gained 12.3% to $38.49 after the company reported better-than-expected Q4 financial results and 2023 expected earnings.
  • EBET, Inc. (NASDAQ: EBET) gained 12.2% to $0.66. EBET recently announced closing of approximately $6.5 million registered direct offering priced at-the-market under Nasdaq rules.
  • Troika Media Group, Inc. (NASDAQ: TRKA) rose 12.4% to $0.2113 after dropping over 5% on Friday.
  • Gaotu Techedu Inc. (NYSE: GOTU) gained 10.3% to $3.3450 after CLSA upgraded the stock from Underperform to Outperform.
  • Youdao, Inc. (NYSE: DAO) gained 10.2% to $7.22.
  • Alteryx, Inc. (NYSE: AYX) jumped 9.2% to $68.68 after Citigroup maintained a Buy rating on the stock and raised its price target from $75 to $80.
  • Millicom International Cellular S.A. (NASDAQ: TIGO) gained 6% to $19.76. Millicom International posted better-than-expected quarterly earnings on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Frequency Therapeutics, Inc. (NASDAQ: FREQ) shares dipped 81.8% to $0.7168 after the company announced its FX-322-208 study failed to meet its primary endpoint.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) fell 60.8% to $ 0.3689 after the company filed for Chapter 11 bankruptcy. Sorrento and its subsidiary, Scintilla Pharmaceuticals, commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code on Monday.
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) fell 54.4% to $3.25 after the company announced it will discontinue its PRESERVE 1 colorectal trial.
  • United Insurance Holdings Corp. (NASDAQ: UIHC) fell 53.2% to $0.96. United Insurance Holdings recently announced the sale of its Florida personal lines renewal rights to Slide Insurance, Inc.
  • Gold Resource Corporation (NYSE: GORO) dropped 36.2% to $1.0396 after the company issued 2023 guidance and suspended its dividend program.
  • Scilex Holding Company (NASDAQ: SCLX) declined 31.3% to $6.60. Sorrento Therapeutics subsidiary Scilex acquires rights to FDA-approved ELYXYB in the US and Canada for acute treatment of migraine.
  • Ecoark Holdings, Inc. (NASDAQ: ZEST) fell 26.4% to $0.2234. Ault Alliance and Ecoark Holdings recently signed a share exchange agreement.
  • Atlis Motor Vehicles, Inc. (NASDAQ: AMV) dropped 26.2% to $1.9200.
  • Genius Brands International, Inc. (NASDAQ: GNUS) dipped 20.9% to $3.5185. The company announced a 1-for-10 reverse stock split last week that went into effect today.
  • IMV Inc. (NASDAQ: IMV) fell 20.7% to $1.5696. IMV announced preliminary data from the VITALIZE Phase 2B trial evaluating its lead DPX product, maveropepimut-S (MVP-S), in combination with Merck & Co’s Keytruda (pembrolizumab) for relapsed, refractory Diffuse Large B Cell Lymphoma (r/r DLBCL).
  • Takung Art Co., Ltd. (NASDAQ: TKAT) fell 20.2% to $1.03.
  • Nuburu, Inc. (NYSE: BURU) dipped 19.3% to $6.26.
  • Guardforce AI Co., Limited (NASDAQ: GFAI) declined 19.1% to $15.30.
  • Tenon Medical, Inc. (NASDAQ: TNON) fell 19% to $1.24.
  • FOXO Technologies Inc. (NASDAQ: FOXO) dropped 19% to $0.8172.
  • Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) fell 17.6% to $0.9889 after gaining 10% on Friday. Lixte Biotechnology recently reported on findings from a team of scientists that its LB-100, combined with an inhibitor of the WEE1 kinase, caused effective cancer cell killing.
  • BigBear.ai Holdings, Inc. (NYSE: BBAI) fell 16.8% to $4.01.
  • SeqLL Inc. (NASDAQ: SQL) dropped 16.7% to $1.1000 after the company announced pricing of an $1.8 million registered direct offering.
  • NanoVibronix, Inc. (NASDAQ: NAOV) fell 16% to $5.08.
  • Fidelity National Information Services, Inc. (NYSE: FIS) declined 14.5% to $64.49 after the company announced 2023 expected financial results below analyst estimates.
  • United Fire Group, Inc. (NASDAQ: UFCS) fell 13.3% to $26.85 after Piper Sandler downgraded the stock from Neutral to Underweight and lowered its price target from $30 to $25.
  • Blue Apron Holdings, Inc. (NYSE: APRN) shares dropped 12.7% to $0.9341 after the company filed an at-the-market equity offering program.
  • Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) fell 12.5% to $1.2250. Citius Pharmaceuticals posted a Q1 loss of $0.02 per share.
  • Soluna Holdings, Inc. (NASDAQ: SLNH) dropped 9.9% to $0.3197.
  • Vaxxinity, Inc. (NASDAQ: VAXX) fell 9.6% to $2.54.
  • Genetic Technologies Limited (NASDAQ: GENE) fell 8% to $1.49 after dropping over 8% on Friday.
  • WeTrade Group, Inc. (NASDAQ: WETG) fell 7% to $0.5070 after dropping 16% on Friday. WeTrade recently said it is prepared to conduct research on the use of ChatGPT style technologies and launch a 'DEMO product similar to ChatGPT'
  • Calyxt, Inc. (NASDAQ: CLXT) fell 6% to $0.3370 after gaining 12% on Friday. Calyxt, last month, agreed to merge with Cibus in an all-stock transaction to create a company focused on agriculture-based gene editing and establish facilities for trait development and next-generation plant breeding.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.